Revisited and large-scale synthesis and purification of the mutated and wild type neu/erbB-2 membrane-spanning segment

被引:9
作者
Khemtemourian, Lucie [1 ]
Lavielle, Sebastien [1 ]
Bathany, Katell [1 ]
Schmitter, Jean-Marie [1 ]
Dufourc, Erick J. [1 ]
机构
[1] Univ Bordeaux 1, CNRS, UMR 5144, MOBIOS,IECB, F-33607 Pessac, France
关键词
solid-phase synthesis; hydrophobic peptide; reversed-phase HPLC; MALDI-ToF mass spectrometry; N-15-labelled amino acids; circular dichroism; alpha-helices;
D O I
10.1002/psc.735
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Solid-phase syntheses of the hydrophobic peptides Neu(TM35) ((1)EQRASPVTFIIATVVGVLLFLILVVVVGILIKRRR(35)) and Neu*(TM35) ((1)EQRASPVTFIIATVEGVLLFLILVVVVGILIKRRR(35)), corresponding to the native and mutated (V15E) transmembrane domain of the neu/erbB-2 tyrosine kinase receptor, respectively, were accomplished using Fmoc chemistry. The use of a new resin and cleavage and purification conditions led to large increases in yields and peptide purity. Two N-15-labelled versions of both wild type and mutated peptides were also synthesized. Approximately 20-40 mg of peptide was obtained using a small-scale synthesis, whereas ca 100 mg of pure peptide was collected on a medium scale. Peptide purity, as monitored by HPLC and mass spectrometry, ranged from 95 to 98% for the six peptides synthesized. Secondary structure as determined by UV circular dichroism (CD) in trifluoroethanol (TFE) showed ca 74% alpha-helical content: for the native peptide and ca 63% for that bearing the mutation. Secondary structure of NeuTM35 was retained in DMPC (dimyristoylphosphatidylcholine)/DCPC (dicaproylphosphatidylcholine) membrane bicelles, and evidences for dimers/oligomers in the lipid bilayer were found. Copyright (c) 2005 European Peptide Society and John Wiley & Sons, Ltd.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 25 条
[1]   Cation modulation of bicelle size and magnetic alignment as revealed by solid-state NMR and electron microscopy [J].
Arnold, A ;
Labrot, T ;
Oda, R ;
Dufourc, EJ .
BIOPHYSICAL JOURNAL, 2002, 83 (05) :2667-2680
[2]   A SUBDOMAIN IN THE TRANSMEMBRANE DOMAIN IS NECESSARY FOR P185NEU-STAR ACTIVATION [J].
CAO, H ;
BANGALORE, L ;
BORMANN, BJ ;
STERN, DF .
EMBO JOURNAL, 1992, 11 (03) :923-932
[3]   Ideally amphipathic β-sheeted peptides at interfaces:: structure, orientation, affinities for lipids and hemolytic activity of (KL)mK peptides [J].
Castano, S ;
Desbat, B ;
Dufourcq, J .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2000, 1463 (01) :65-80
[4]   The amphipathic helix concept:: length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity [J].
Castano, S ;
Cornut, I ;
Büttner, K ;
Dasseux, JL ;
Dufourcq, J .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1416 (1-2) :161-175
[5]   Transmembrane domain sequence requirements for activation of the p185(c-neu) receptor tyrosine kinase [J].
Chen, LI ;
Webster, MK ;
Meyer, AN ;
Donoghue, DJ .
JOURNAL OF CELL BIOLOGY, 1997, 137 (03) :619-631
[6]  
FIELDS C G, 1991, Peptide Research, V4, P95
[7]   Preparation of insoluble transmembrane peptides: Glycophorin-A, prion (110-137), and FGFR (368-397) [J].
Glover, KJ ;
Martini, PM ;
Vold, RR ;
Komives, EA .
ANALYTICAL BIOCHEMISTRY, 1999, 272 (02) :270-274
[8]   Evidence for an α-helix → π-bulge helicity modulation for the neu/erbB-2 membrane-spanning segment.: A 1H NMR and circular dichroism study [J].
Goetz, M ;
Carlotti, C ;
Bontems, F ;
Dufourc, EJ .
BIOCHEMISTRY, 2001, 40 (21) :6534-6540
[9]  
Goetz M, 1999, J PEPT SCI, V5, P245, DOI 10.1002/(SICI)1099-1387(199906)5:6<245::AID-PSC187>3.0.CO
[10]  
2-Q